Home › Funds › KEYSTONE INVESTORS PTE LTD › DFTX
KEYSTONE INVESTORS PTE LTD position in DFTX
DEFINIUM THERAPEUTICS INC · Health Care
KEYSTONE INVESTORS PTE LTD reported holding 221,080 shares of DFTX (DEFINIUM THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$8.4M, representing 0.34% of its reported portfolio and ranking #34 among its reported holdings. KEYSTONE INVESTORS PTE LTD has disclosed DFTX holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How KEYSTONE INVESTORS PTE LTD's DFTX position evolved
KEYSTONE INVESTORS PTE LTD first disclosed a stake in DFTX in Q2 2026 at 95,100 shares (US$4.5M). The position peaked in Q3 2026 at 221,080 shares, worth US$8.4M. Across 2 filings, KEYSTONE INVESTORS PTE LTD increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 221,080 shares valued at US$8.4M — an increase of 125,980 shares quarter over quarter.. Notable position changes include a 132% increase in Q3 2026 (shares fell 16% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 95.10K | $4.47M | New |
| Q3 2026 | 221.08K | $8.41M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About DFTX and 13F data
DFTX (DEFINIUM THERAPEUTICS INC) is a Health Care company. 133 other funds we track also report a position in DFTX — the largest reported positions include Avoro Capital Advisors LLC (US$268.3M), DRIEHAUS CAPITAL MANAGEMENT LLC (US$258.4M), Octagon Capital Advisors LP (US$138.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding DFTX
- Avoro Capital Advisors LLC 7.05M sh · $268.32M · Q3 2026
- DRIEHAUS CAPITAL MANAGEMENT LLC 6.79M sh · $258.35M · Q3 2026
- Octagon Capital Advisors LP 2.95M sh · $138.77M · Q2 2026
- Commodore Capital LP 2.00M sh · $94.08M · Q2 2026
- RA CAPITAL MANAGEMENT, L.P. 1.50M sh · $70.56M · Q2 2026
- Boxer Capital Management, LLC 998.50K sh · $46.97M · Q2 2026
- Deep Track Capital, LP 1.00M sh · $38.06M · Q3 2026
- AWM Investment Company, Inc. 764.80K sh · $29.11M · Q3 2026
- Catalio Capital Management, LP 562.67K sh · $26.47M · Q2 2026
- GREAT POINT PARTNERS LLC 425.00K sh · $19.99M · Q2 2026
- Integral Health Asset Management, LLC 500.00K sh · $19.03M · Q3 2026
- Ally Bridge Group (NY) LLC 400.00K sh · $18.82M · Q2 2026
More on KEYSTONE INVESTORS PTE LTD
FAQ
How long has KEYSTONE INVESTORS PTE LTD held DFTX?
KEYSTONE INVESTORS PTE LTD has disclosed DFTX holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is KEYSTONE INVESTORS PTE LTD's current position in DFTX?
As of Q3 2026, KEYSTONE INVESTORS PTE LTD holds 221.08K shares of DFTX (DEFINIUM THERAPEUTICS INC), valued at $8.41M, representing 0.34% of its reported portfolio and ranking #34.
Has KEYSTONE INVESTORS PTE LTD been buying or selling DFTX?
In the latest 13F filing (Q3 2026), KEYSTONE INVESTORS PTE LTD increased its position in DFTX. The position peaked in Q3 2026 at 221.08K shares.
Which other funds hold DFTX?
Other major institutional holders of DFTX include Avoro Capital Advisors LLC, DRIEHAUS CAPITAL MANAGEMENT LLC, Octagon Capital Advisors LP, among 133 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.